Insider Transactions in Q1 2021 at Galectin Therapeutics Inc (GALT)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
7,680
+3.66%
|
$15,360
$2.17 P/Share
|
|
Mar 15
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,667
+3.32%
|
$13,334
$2.5 P/Share
|
|
Mar 05
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
27,027
+11.18%
|
$54,054
$2.22 P/Share
|
|
Mar 01
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$20,000
$2.31 P/Share
|
|
Feb 26
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
7,440
+3.81%
|
$14,880
$2.24 P/Share
|
|
Feb 15
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,693
+3.58%
|
$13,386
$2.49 P/Share
|
|
Feb 02
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$20,000
$2.04 P/Share
|
|
Jan 29
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,503
+4.67%
|
$8,503
$1.96 P/Share
|
|
Jan 15
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
7,610
+4.41%
|
$15,220
$2.19 P/Share
|
|
Jan 11
2021
|
Gilbert F Amelio |
SELL
Open market or private sale
|
Direct |
60,000
-49.75%
|
$120,000
$2.17 P/Share
|
|
Jan 04
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$20,000
$2.23 P/Share
|